This 6-part podcast mini-series, organized and supported by Bayer, is intended for healthcare professionals practicing in the US. Our aim is to raise awareness of the importance of early diagnosis and appropriate management of chronic kidney disease (CKD) in patients with type 2 diabetes in order to slow progression of CKD and reduce the risk of premature cardiovascular morbidity and mortality.
Patient education and activation is important in early disease management, and includes self-care, monitoring, and adherence to treatment plans.
Patient support groups and resources are available for patients with CKD associated with T2D.
Early management of CKD associated with T2D offers numerous advantages.
This is episode 5 of a 6-part podcast mini-series, organized and supported by Bayer, is intended for healthcare professionals practicing in the US. Our aim is to raise awareness of the importance of early diagnosis and appropriate management of chronic kidney disease (CKD) in patients with type 2 diabetes in order to slow progression of CKD and reduce the risk of premature cardiovascular morbidity and mortality.
Drs. Susanne B. Nicholas (Nephrologist and Professor of Medicine and Clinical Hypertension Specialist in the Division of Nephrology at UCLA) and Jay H. Shubrook (Primary Care Physician/Diabetologist and Professor in the Primary Care Department at Touro University of California) discuss the importance of patient education and activation in early disease management and highlight the role of support groups and resources